FDA Hearing On Proposal To Withdraw Approval For Avastin

Priscilla Howard, from left, Crystal Hanna, and Nancy Haunty, all breast cancer patients, listen to testimony during a Food and Drug Administration (FDA) hearing in Silver Spring, Maryland, U.S., on Tuesday, June 28, 2011. Breast-cancer patients and their families urged U.S. regulators to back down from a plan to withdraw approval for Roche Holding AG's Avastin, saying the treatment offered significant benefits for some women. Photographer: Joshua Roberts/Bloomberg via Getty Images
Priscilla Howard, from left, Crystal Hanna, and Nancy Haunty, all breast cancer patients, listen to testimony during a Food and Drug Administration (FDA) hearing in Silver Spring, Maryland, U.S., on Tuesday, June 28, 2011. Breast-cancer patients and their families urged U.S. regulators to back down from a plan to withdraw approval for Roche Holding AG's Avastin, saying the treatment offered significant benefits for some women. Photographer: Joshua Roberts/Bloomberg via Getty Images
FDA Hearing On Proposal To Withdraw Approval For Avastin
PURCHASE A LICENCE
How can I use this image?
₹23,000.00
INR

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
117576083
Collection:
Bloomberg
Date created:
28 June, 2011
Upload date:
Licence type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
FDA AVASTIN